Drugplain

Riomet 500 mg/5mL

Metformin Hydrochloride · SOLUTION · Sun Pharmaceutical Industries, Inc.

4 Recalls on Record
Plain English

Riomet is a liquid oral medication containing metformin that is used to treat type 2 diabetes by helping control blood sugar levels. It comes as a solution with 500 mg of metformin in each 5 mL dose and requires a prescription.

Key Facts

Brand Name
Riomet
Generic Name
Metformin Hydrochloride
NDC Code (Product)
10631-206
Manufacturer
Sun Pharmaceutical Industries, Inc.
Strength
500 mg/5mL
Dosage Form
SOLUTION
Route
ORAL
Marketing Status
Application #
NDA021591
Marketing Start
01/04/2004

Recall History

4 Recalls on Record
Class II09/23/2020

SUN PHARMACEUTICAL INDUSTRIES INC

CGMP Deviations: Detection of N-nitrosodimethylamine (NDMA) impurity in finished drug product.

TerminatedVoluntary: Firm initiated
Class II04/18/2017

Sun Pharmaceutical Industries, Inc.

Microbial Contamination of Non-Sterile Products

TerminatedVoluntary: Firm initiated
Class II03/31/2021

SUN PHARMACEUTICAL INDUSTRIES INC

Microbial Contamination of Non-Sterile Product

TerminatedVoluntary: Firm initiated
Class III04/26/2018

Sun Pharmaceutical Industries, Inc.

Labeling: Not Elsewhere Classified: Sun Pharma has decided to initiate this recall in response to identified labeling discrepancies in the patient literature.

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

lactic acidosis4,236 reports
diarrhoea4,105 reports
nausea3,361 reports
acute kidney injury2,989 reports
fatigue2,943 reports
drug ineffective2,618 reports
dyspnoea2,489 reports
vomiting2,480 reports
headache2,147 reports
off label use2,063 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

1 INDICATIONS AND USAGE RIOMET is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. RIOMET is a biguanide indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. (1)

Dosage & Administration

2 DOSAGE AND ADMINISTRATION Adult Dosage for RIOMET : • Starting dose: 500 mg (5 mL) orally twice a day or 850 mg (8.5 mL) once a day, with meals (2.1) • Increase the dose in increments of 500 mg (5 mL) weekly or 850 mg (8.5 mL) every 2 weeks, up to a maximum dose of 2,550 mg (25.5 mL) per day, given in divided doses (2.1) • Doses above 2,000 mg (20 mL) may be better tolerated given in divided doses 3 times a day with meals (2.1) Pediatric Dosage for RIOMET : • Starting dose: 500 mg (5 mL) orally twice a day, with meals (2.2) • Increase dosage in increments of 500 mg (5 mL) weekly up to a maximum of 2,000 mg (20 mL) per day, given in divided doses twice daily (2.2) Renal Impairment : • Prior to initiation, assess renal function with estimated glomerular filtration rate (eGFR) (2.3) • Do not use in patients with eGFR below 30 mL/minute/1.73 m 2 (2.3) • Initiation is not recommended in patients with eGFR between 30 to 45 mL/minute/1.73 m 2 (2.3) • Assess risk/benefit of continuing RIOMET if eGFR falls below 45 mL/minute/1.73 m 2 (2.3) • Discontinue if eGFR falls below 30 mL/minute/1.73 m 2 (2.3) Discontinuation for Iodinated Contrast Imaging Procedures: • RIOMET may need to be discon

Contraindications

4 CONTRAINDICATIONS 1. RIOMET is contraindicated in patients with: 2. Severe renal impairment (eGFR below 30 mL/min/1.73 m 2 ) [see Warnings and Precautions (5.1) ]. 3. Hypersensitivity to metformin. 4. Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. • Severe renal impairment (eGFR below 30 mL/min/1.73 m 2 ) (4, 5.1) • Hypersensitivity to metformin (4) • Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. (4)

Drug Interactions

7 DRUG INTERACTIONS 1. Table 2 presents clinically significant drug interactions with RIOMET. 2. Table 2: Clinically Significant Drug Interactions with RIOMET 1. Carbonic Anhydrase Inhibitors 1. Clinical Impact: 1. Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with RIOMET may increase the risk for lactic acidosis. 1. Intervention: 1. Consider more frequent monitoring of these patients. 1. Examples: 1. Topiramate, zonisamide, acetazolamide or dichlorphenamide. 1. Drugs that Reduce RIOMET Clearance 1. Clinical Impact: 1. Concomitant use of drugs that interfere with common renal tubular transport systems involved in the renal elimination of metformin (e.g., organic cationic transporter-2 [OCT 2 ] / multidrug and toxin extrusion [MATE] inhibitors) could increase systemic exposure to metformin and may increase the risk for lactic acidosis [see Clinical Pharmacology (12.3)]. 1. Intervention: 1. Consider the benefits and risks of concomitant use with RIOMET. 1. Examples: 1. Ranolazine, vandetanib, dolutegravir, and cimetidine. 1. Alcohol 1. Clinical Impact: 1. Alcoh

Adverse Reactions

6 ADVERSE REACTIONS • The following adverse reactions are also discussed elsewhere in the labeling: • Lactic Acidosis [see Boxed Warning and Warnings and Precautions (5.1)] • Vitamin B 12 Deficiency [see Warnings and Precautions (5.2)] • Hypoglycemia [see Warnings and Precautions (5.3)] The most common adverse reactions are diarrhea, nausea/vomiting, flatulence, asthenia, indigestion, abdominal discomfort, and headache. (6.1) To report SUSPECTED ADVERSE REACTIONS, contact Sun Pharmaceutical Industries, Inc. at 1-800-818-4555 or FDA at 1-800-FDA-1088 or http://www.fda.gov/medwatch 6.1 Clinical Studies Experience 1. Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. 2. In a U.S. clinical trial of metformin HCl tablets in patients with type 2 diabetes mellitus, a total of 141 patients received metformin HCl tablets up to 2,550 mg per day. Adverse reactions reported in greater than 5% of patients treated with metformin HCl tablets and that were more common than in placebo-trea

Frequently Asked Questions

What is Riomet used for?

Riomet is a liquid oral medication containing metformin that is used to treat type 2 diabetes by helping control blood sugar levels. It comes as a solution with 500 mg of metformin in each 5 mL dose and requires a prescription.

Is Riomet a controlled substance?

Riomet is not classified as a controlled substance by the DEA.

What is the generic name for Riomet?

The generic name for Riomet is Metformin Hydrochloride. There are 11 other brand versions of Metformin Hydrochloride.

What is the NDC code for Riomet 500 mg/5mL?

The NDC (National Drug Code) for Riomet 500 mg/5mL is 10631-206, listed by Sun Pharmaceutical Industries, Inc..